Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lumicell
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lumicell

Lumicell

Series A

US-based Lumicell, a biotech firm, innovates image-guided solutions for cancer surgeries.

HQ
Wellesley, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Lumicell is a biotechnology company based in Wellesley, United States, focused on developing and marketing image-guided cancer surgery solutions. Their core mission is to enhance the precision of cancer surgeries by providing innovative imaging technologies that help surgeons detect and remove residual cancerous tissue. The company's flagship product, LUMISIGHT™, is designed to illuminate cancerous tissues during breast-conserving surgeries, aiming to improve surgical outcomes and reduce the need for follow-up procedures.

Lumicell has achieved significant milestones, including historic FDA approval for its cutting-edge imaging platform. The company has also received a positive recommendation from an FDA advisory committee regarding the benefit-risk profile of LUMISIGHT™. Lumicell regularly presents its research and advancements at prominent industry events such as the Society of Surgical Oncology Annual Meeting, underscoring its commitment to advancing fluorescence-guided surgery.

Lumicell - Similar Companies

OnLume logo

OnLume

onlume.com

Avelas Biosciences logo

Avelas Biosciences

LumaCyte logo

LumaCyte

lumacyte.com

On Target Laboratories logo

On Target Laboratories

Cellens logo

Cellens

cellensinc.com

Lumeda logo

Lumeda

lumedainc.com

Vergent Bioscience logo

Vergent Bioscience

vergentbio.com

Lucence logo

Lucence

lucence.com

LsBioPath logo

LsBioPath

lsbiopath.com

Blaze Bioscience logo

Blaze Bioscience

Droplet Biosciences logo

Droplet Biosciences

dropletbiosci.com

Lumedica logo

Lumedica

Luminostics logo

Luminostics

Elucent Medical logo

Elucent Medical

elucentmedical.com

Oncocyte logo

Oncocyte

oncocyte.com

Lumicell - Quick Facts

Who are Lumicell's competitors?

Companies similar to Lumicell include OnLume, Avelas Biosciences, LumaCyte and On Target Laboratories.

When was Lumicell founded?

Lumicell was founded in 2008.

Where is Lumicell's headquarters located?

Lumicell's headquarters is located in Wellesley, MA, US.

When was Lumicell's last funding round?

Lumicell's most recent funding round was for $9M (USD) in September 2022.

How much has Lumicell raised to-date?

As of Sep 1, 2022, Lumicell has raised a total of $77.8M (USD).

How many employees does Lumicell have?

Lumicell has 64 employees as of Feb 5, 2024.

Lumicell - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Detection
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8731Commercial Physical and Biological Research